Caffeine, cognitive functioning, and white matter lesions in the elderly: establishing causality from epidemiological evidence.

The present study examines the epidemiological evidence for a causal relationship between caffeine consumption and cognitive deterioration in the elderly. Using a population of 641 elderly persons, we examined cognitive functioning, caffeine consumption, magnetic resonance imaging volumetrics, and other factors known to affect cognitive performance. Our findings demonstrate the association between caffeine consumption and lower cognitive change over time to be statistically significant for women only, taking into account multiple confounders, to be dose-dependent and temporarily related (caffeine consumption precedes cognitive change). Mean log transformed white matter lesion/cranial volume ratios were found to be significantly lower in women consuming more than 3 units of caffeine per day after adjustment for age (-1.23 SD=0.06) than in women consuming 2-3 units (-1.04 SD=0.04) or one unit or less (-1.04 SD=0.07, -35% in cm3 compared to low drinkers). This observation is coherent with biological assumptions that caffeine through adenosine is linked to amyloid accumulation and subsequently white matter lesion formation. The significant relationship observed between caffeine intake in women and lower cognitive decline is highly likely to be a true causal relationship and not a spurious association.

[1]  F. Pasquier,et al.  Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. , 2009, Archives of internal medicine.

[2]  Jordan Muraskin,et al.  Structural neuroimaging in Alzheimer's disease: do white matter hyperintensities matter? , 2009, Dialogues in clinical neuroscience.

[3]  Yaakov Stern,et al.  Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging , 2009, Psychiatry Research: Neuroimaging.

[4]  H R Lieberman,et al.  The effects of ginseng, ephedrine, and caffeine on cognitive performance, mood and energy. , 2009, Nutrition reviews.

[5]  F. Pedata,et al.  Adenosine A2A receptors and brain injury: Broad spectrum of neuroprotection, multifaceted actions and “fine tuning” modulation , 2007, Progress in Neurobiology.

[6]  D. Souza,et al.  Caffeine and adenosine A2a receptor antagonists prevent β-amyloid (25–35)-induced cognitive deficits in mice , 2007, Experimental Neurology.

[7]  L. Zacharia,et al.  Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain β-amyloid production , 2006, Neuroscience.

[8]  Eric E. Smith,et al.  Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy , 2006, Neurology.

[9]  R. Holman,et al.  Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study Population , 2003, Neuroepidemiology.

[10]  J. Jolles,et al.  The effects of habitual caffeine use on cognitive change: a longitudinal perspective , 2003, Pharmacology Biochemistry and Behavior.

[11]  A. Mendonça,et al.  Adenosine receptors in the nervous system: pathophysiological implications , 2002, Progress in Neurobiology.

[12]  E. Barrett-Connor,et al.  Coffee consumption and cognitive function among older adults. , 2002, American journal of epidemiology.

[13]  R. Hébert,et al.  Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. , 2002, American journal of epidemiology.

[14]  A. de Mendonça,et al.  Does caffeine intake protect from Alzheimer's disease? , 2002, European journal of neurology.

[15]  J. Jolles,et al.  Habitual caffeine consumption and its relation to memory, attention, planning capacity and psychomotor performance across multiple age groups , 2000, Human psychopharmacology.

[16]  B. Fredholm,et al.  Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. , 1999, Pharmacological reviews.

[17]  B. Fredholm,et al.  Caffeine--an atypical drug of dependence. , 1998, Drug and alcohol dependence.

[18]  A. B. Hill.  The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[19]  H. Soininen,et al.  Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. , 2009, Journal of Alzheimer's disease : JAD.

[20]  V. Echeverria,et al.  Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice. , 2009, Journal of Alzheimer's disease : JAD.

[21]  J. Growdon,et al.  Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. , 2006, Neurology.

[22]  M. Jarvis,et al.  Does caffeine intake enhance absolute levels of cognitive performance? , 2005, Psychopharmacology.

[23]  C. Rorden,et al.  Stereotaxic display of brain lesions. , 2000, Behavioural neurology.

[24]  L. Radloff.  The CES-D Scale: A Self-Report Depression Scale for Research in the General Population — Source link , 2022 .